Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Back
General Research Article

Study and Determination of Aluminum in Dextran 40 Glucose Injection by ICP-MS

Author(s): Si-Qi Zhu, Ji-Wu Liu*, Xiao Gu, Jin-Qi Zheng* and Pei-Xi Zhu

Volume 18, Issue 1, 2022

Published on: 18 January, 2021

Page: [82 - 87] Pages: 6

DOI: 10.2174/1573412917666210118120331

Abstract

Background: Aluminum (Al) is classified as other elements by ICH, and its permitted daily exposure (PDE) has not been established. As it might cause compromised renal function, guidelines, regional regulations and practices need to be addressed. According to the United States Pharmacopeia 41 and the Japanese Pharmacopoeia 17, the aluminum content of large-volume parenterals (LVPs) used in total parenteral nutrition (TPN) therapy must not exceed 25 ng mL-1. Therefore, the package insert of LVPs used in TPN therapy must state the content of aluminum.

Objective: A new microwave assisted acid digestion pretreatment together with inductively coupled plasma mass spectrometry (ICP-MS) method was developed for the determination of aluminum content in Dextran 40 Glucose Injection. The method was successfully applied for quality evaluation of commercial Dextran 40 Glucose Injection.

Methods: Samples were digested by a mixture of nitric acid and hydrochloric acid, with the assistance of microwave. After that, ICP-MS in KED mode was employed to analyze the samples.

Results: The method showed a good linearity (r2=0.9999) within the range of 2~100 ng mL-1, with the limit of detection and quantitation of 0.482 ng mL-1 and 1.61 ng mL-1, respectively. A good precision was obtained with relative standard deviation (RSD) of 8.8% (n=6). The spike recoveries with low, middle and high Al content in 9 sample were 102.2%~107.4%.

Conclusion: The developed method was successfully applied for the analysis of Al content in 44 batches of Dextran 40 Glucose Injection produced by 9 pharmaceutical companies from domestic or international enterprises. The Al content of Dextran 40 Glucose Injection varied greatly between different enterprises or different batches. Meanwhile, among total of 44 batches, the Al content in 3 batches of Dextran 40 Glucose Injection exceeded the limitation of 25 ng mL-1, which might cause potential safety problems.

Keywords: Aluminum, Dextran 40 Glucose Injection, ICP-MS, elemental impurity, microwave digestion, USP<233>.

« Previous
Graphical Abstract

[1]
Naessens, M.; Cerdobbel, A.; Soetaert, W.; Vandamme, E. Leuconostoc dextransucrase and dextran: production, properties and applications. J. Chem. Technol. Biotechnol., 2005, 80(8), 845-860.
[http://dx.doi.org/10.1002/jctb.1322]
[2]
Ljungström, K.G. Pretreatment with dextran 1 makes dextran 40 therapy safer. J. Vasc. Surg., 2006, 43(5), 1070-1072.
[http://dx.doi.org/10.1016/j.jvs.2005.11.056] [PMID: 16678710]
[3]
Hehre, E.J.; Hamilton, D.M. Bacterial conversion of dextrin into a polysaccharide with the serological properties of dextran. Proc. Soc. Exp. Biol. Med., 1949, 71(3), 336-339.
[http://dx.doi.org/10.3181/00379727-71-17183] [PMID: 18136472]
[4]
Barker, S.; Bourne, E.; Bruce, G.; Stacey, M. Immunopolysaccharides. Part XI. Structure of an Acetobacter capsulatum dextran. J. Am. Chem. Soc., 1958, 4, 4414-4416.
[http://dx.doi.org/10.1039/jr9580004414]
[5]
Salemark, L.; Wieslander, J.B.; Dougan, P.; Arnljots, B. Studies of the antithrombotic effects of dextran 40 following microarterial trauma. Br. J. Plast. Surg., 1991, 44(1), 15-22.
[http://dx.doi.org/10.1016/0007-1226(91)90170-O] [PMID: 1704269]
[6]
Robless, P.A.; Tegos, T.J.; Okonko, D.; Mansfield, A.O.; Nicolaides, A.N.; Mikhailidis, D.P.; Stansby, G. Platelet activation during carotid endarterectomy and the antiplatelet effect of Dextran 40. Platelets, 2002, 13(4), 231-239.
[http://dx.doi.org/10.1080/09537100220144849] [PMID: 12189025]
[7]
Robless, P.; Okonko, D.; Mikhailidis, D.P.; Stansby, G. Dextran 40 reduces in vitro platelet aggregation in peripheral arterial disease. Platelets, 2004, 15(4), 215-222.
[http://dx.doi.org/10.1080/09537100410001682814] [PMID: 15203712]
[8]
Ar’Rajab, A.; Ahrén, B.; Sundberg, R.; Bengmark, S. A new dextran 40-based solution for liver preservation. Transplantation, 1992, 53(4), 742-745.
[http://dx.doi.org/10.1097/00007890-199204000-00006] [PMID: 1373533]
[9]
Liu, X.; Wu, X.; Ye, T.; Tian, Y.; Wang, J. Evaluation of the efficiency and safety of the compound dextran 40 injection used in the operation. Chin. New Drug J., 2007, 16, 1514-1519.
[10]
The International Conference on Harmonization of Technical Requirements and Registration of Pharmaceuticals for Human Use (ICH), Guideline for Elemental Impurities Q3D., 2013.
[11]
Smith, B.S.; Kothari, H.; Hayes, B.D.; Tataronis, G.; Hudlin, M.; Doole, J.; Hartman, C. Effect of additive selection on calculated aluminum content of parenteral nutrient solutions. Am. J. Health Syst. Pharm., 2007, 64(7), 730-739.
[http://dx.doi.org/10.2146/ajhp060163] [PMID: 17384359]
[12]
Wang, X.; Han, F.; Xiang, T. Determination of Aluminium in some large volume injections by ICP-MS, Drug Standard. Chin., 2009, 04, 271-273.
[13]
Han, F.; Sun, X.; Dong, Y.; Wang, X. Determination of aluminum in some injections by ICP-MS. Pract. Pharm. Clin. Remed., 2010, 03, 195-196.
[14]
Li, Y.; Gao, G. Determination of residual aluminum in compound amino acid injection by graphite furnace atomic absorption spectroscopy standard addition method. Chin. J. Mod. Drug Appl., 2016, 15, 280-282.
[http://dx.doi.org/10.1080/17535654.2016.1237490]
[15]
Shan, H.; Liu, X.; Xu, Y. Determination of aluminum in Milrinone injection by ICP-MS. J. Pharm. Res., 2013, 32(2), 83-84.
[16]
Zhang, J.; Yang, Y.; Zhang, Y.; Bo, S.; Wang, G.; Xin, X.; Wang, J. Development and verification of inductively coupled plasma-mass spectrometry for determination of aluminum content in mite allergen injection. Zhongguo Shengwuzhipinxue Zazhi, 2014, 27(9), 1207-1210.
[17]
Ma, C.; Meng, C.; Zhang, C.; Chen, X.; Wang, B.; Ren, X. Correction of matrix effect in determination of heavy metal elements in iron dextran by icp-oes internal standard method. Yaowu Pingjia Yanjiu, 2017, 40(8), 1098-1102.
[18]
Chen, M.; Yang, H.; Wang, Q.; Sun, Q. Determination of aluminum in compound amino acid injection by ICP-MS, Drug Standard. Chin., 2019, 20(3), 237-241.
[19]
<233> Elemental Impurities—Procedures, in: Second Suppl. to United States Pharmacop. Natl. Formul. (USP 41-NF 33), United States Pharmacopeia Convention., 2017.
[20]
Gan, Z.; Ma, F.; Li, J. Potential Source of Aluminum in Compound Amino Acid Injection. Hera. Med., 2018, 37(7), 865-868.

Rights & Permissions Print Cite
Article Metrics
18
1
© 2024 Bentham Science Publishers | Privacy Policy